Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600135001) titled 'Clinical research on the correlation of prosaposin in diabetes and diabetes-related cognitive dysfunction' on Oct. 22.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Condition:
type 2 diabetes, diabetes associated cognitive disease
Intervention:
T2DM:N/A
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-22
Target Sample Size: T2DM:12;Healthy control group:12;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.htm...